AT395587B - Herstellung und verwendung neuer azolderivate, und sie enthaltende pharmazeutische praeparate - Google Patents

Herstellung und verwendung neuer azolderivate, und sie enthaltende pharmazeutische praeparate Download PDF

Info

Publication number
AT395587B
AT395587B AT0316887A AT316887A AT395587B AT 395587 B AT395587 B AT 395587B AT 0316887 A AT0316887 A AT 0316887A AT 316887 A AT316887 A AT 316887A AT 395587 B AT395587 B AT 395587B
Authority
AT
Austria
Prior art keywords
formula
compounds
acid addition
addition salts
phenyl
Prior art date
Application number
AT0316887A
Other languages
German (de)
English (en)
Other versions
ATA316887A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA316887A publication Critical patent/ATA316887A/de
Application granted granted Critical
Publication of AT395587B publication Critical patent/AT395587B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT0316887A 1986-12-03 1987-12-02 Herstellung und verwendung neuer azolderivate, und sie enthaltende pharmazeutische praeparate AT395587B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3641320 1986-12-03

Publications (2)

Publication Number Publication Date
ATA316887A ATA316887A (de) 1992-06-15
AT395587B true AT395587B (de) 1993-01-25

Family

ID=6315380

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0316887A AT395587B (de) 1986-12-03 1987-12-02 Herstellung und verwendung neuer azolderivate, und sie enthaltende pharmazeutische praeparate

Country Status (24)

Country Link
JP (1) JPH0678318B2 (fr)
KR (1) KR880007481A (fr)
AT (1) AT395587B (fr)
AU (1) AU605522B2 (fr)
BE (1) BE1001235A4 (fr)
CH (1) CH677925A5 (fr)
DK (1) DK631287A (fr)
ES (1) ES2010235A6 (fr)
FI (1) FI875300A (fr)
FR (1) FR2607810B1 (fr)
GB (1) GB2199579B (fr)
GR (1) GR871897B (fr)
HU (1) HU198694B (fr)
IL (1) IL84665A (fr)
IT (1) IT1211944B (fr)
LU (1) LU87063A1 (fr)
MY (1) MY103004A (fr)
NL (1) NL8702897A (fr)
NZ (1) NZ222765A (fr)
PH (1) PH24666A (fr)
PL (1) PL151588B1 (fr)
PT (1) PT86255B (fr)
SE (1) SE8704792L (fr)
ZA (1) ZA879093B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
UA41295C2 (uk) * 1991-09-02 2001-09-17 Яманугі Фармасетікл Ко., Лтд Триазолілзаміщені третинні амінні сполуки або їх солі як інгібітор ароматази та фармацевтична композиція на їх основі
GB9409882D0 (en) * 1994-05-18 1994-07-06 Sandoz Ltd Organic compounds
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT382868B (de) * 1983-03-11 1987-04-27 Sandoz Ag Verfahren zur herstellung neuer azolderivate und deren salze

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT382868B (de) * 1983-03-11 1987-04-27 Sandoz Ag Verfahren zur herstellung neuer azolderivate und deren salze

Also Published As

Publication number Publication date
PT86255A (en) 1988-06-01
DK631287A (da) 1988-06-04
AU605522B2 (en) 1991-01-17
IT1211944B (it) 1989-11-08
GB8727978D0 (en) 1988-01-06
PL151588B1 (en) 1990-09-28
IL84665A0 (en) 1988-05-31
PL269180A1 (en) 1988-08-18
HUT45506A (en) 1988-07-28
MY103004A (en) 1993-03-31
IL84665A (en) 1991-11-21
ES2010235A6 (es) 1989-11-01
AU8196287A (en) 1988-06-16
BE1001235A4 (fr) 1989-08-29
FR2607810B1 (fr) 1989-12-01
HU198694B (en) 1989-11-28
CH677925A5 (fr) 1991-07-15
ATA316887A (de) 1992-06-15
GB2199579B (en) 1990-07-18
FR2607810A1 (fr) 1988-06-10
PH24666A (en) 1990-09-07
GB2199579A (en) 1988-07-13
FI875300A (fi) 1988-06-04
NZ222765A (en) 1990-11-27
NL8702897A (nl) 1988-07-01
DK631287D0 (da) 1987-12-01
IT8748656A0 (it) 1987-12-01
JPS63145270A (ja) 1988-06-17
PT86255B (pt) 1990-11-07
KR880007481A (ko) 1988-08-27
FI875300A0 (fi) 1987-12-01
SE8704792D0 (sv) 1987-12-01
ZA879093B (en) 1989-07-26
LU87063A1 (fr) 1988-07-14
GR871897B (en) 1988-04-04
JPH0678318B2 (ja) 1994-10-05
SE8704792L (sv) 1988-06-04

Similar Documents

Publication Publication Date Title
DE3218584C2 (fr)
DE69627831T2 (de) Benzopyran-enthaltende verbindungen und verfahren zu deren verwendung
DE3874073T2 (de) Aromatasehemmende 4(5)-imidazole.
DE102005008310A1 (de) Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle
EP0770613A1 (fr) Dérivés substitués de l'imidazolidin-2,4 dione comme immunomodulateurs
DE3887151T2 (de) Inhibitoren für zellenzuwachs und methoden für krebsbehandlung.
DE2643670C2 (de) 5-Benzyl-4-pyrimidon-Derivate, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2160946A1 (de) Aminosäureamide disubstituierter Phenathylamine
DE69828999T2 (de) 1-(4-(1-(4-fluorophenyl)-1h-indol-3-yl)1-butyl)-spiro-(isobenzofuran-1(3h),4'-pperidin)-hydrohalogenide
DE2643936A1 (de) Arzneimittel mit erythropoietischer wirksamkeit
AT395587B (de) Herstellung und verwendung neuer azolderivate, und sie enthaltende pharmazeutische praeparate
DE2616481A1 (de) Bis-quartaere pyridinium-2-aldoxim- salze und verfahren zu ihrer herstellung
EP0304534A1 (fr) Dérivés de la dihydropyridazinone, procédé pour leur préparation et médicaments contenant ces composés
EP0411735B1 (fr) Cycloalkylène-azoles, leur procédé de préparation, formes pharmaceutiques les contenant ainsi que leur application à la préparation de médicaments
EP0283857B1 (fr) Dérivés de benzylidenamino-, benzylamino- et benzoylamino-imidazoles
DE68912263T2 (de) 4-Methyl-5[2-(4-phenyl-1-piperazinyl)-ethyl]-Thiazolderivate, ihre Herstellung und Zusammenstellungen, die sie enthalten.
DE3877124T2 (de) Imidazol-derivate, verfahren zu deren herstellung und deren anwendung als alpha-2-adrenoceptor-antagonisten.
DE1470284B1 (de) Beta-{1-Methyl-4-[1-methyl-4-(1-methyl-4-formylamino-pyrrol-2-carboxamido)-pyrrol-2-carboxamido]-pyrrol-2-carboxamido}-propionamidin sowie dessen Saeureadditionssalze
DE3740125A1 (de) Azolderivate
CH641167A5 (en) N-Cyano-N'-(2-((4-methyl-5-imidazolyl)-methylthio)ethyl)-N''-alkyny l guanidines
EP0003286B1 (fr) Dérivés d'alcaloides ergopeptidiques, procédé pour leur préparation et compositions pharmaceutiques les contenant
DE2917890C2 (fr)
DE2311177A1 (de) O-(dialkylaminoalkyl)-1-alkyl-5nitroimidazol-(2)-aldoxime und verfahren zu ihrer herstellung
DE2614137C2 (de) Benzo[b]thien(2)-ylaminoäthylketone, Verfahren zu ihrer Herstellung, sowie diese enthaltende Arzneimittel
DE1620200C3 (de) 7-Oxo-desacetamido-colchicinderivate, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel. Ausscheidung aus: 1235322

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee